The interplay Between Atrial Fibrillation and Sudden Cardiac Death - Martin Borggrefe

↳ This is a section part of Moment: ISCP 2017 - Sudden Cardiac Death and Syncope - Joint Session ISCP and ESC WG of Pharmacotherapy

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

The interplay Between Atrial Fibrillation and Sudden Cardiac Death - Presented by Martin Borggrefe at ISCP 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Cardiologists, interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians

Learning Objectives

Other Components in this Moment

Overview
Welcome and Opening Ceremony of the ISCP Congress 2017 - Antoni Martínez-Rubio
Syncope: Differential Diagnoses and Signs of High Risk - Ángel Moya
Pharmacotherapy in Neurocardiogenic Syncope: New Options - Carlos Morillo
Primary and Secondary Prevention of Sudden Cardiac Death in Ischemic Heart Disease and Myocardiopathies: Do Drugs Have any Role? - Juergen Kuschyck
Primary and Secondary Prevention of Sudden Cardiac Death in Channelopathies: Role of Drugs and Devices - Josep Brugada
The interplay Between Atrial Fibrillation and Sudden Cardiac Death - Martin Borggrefe
Current Perspectives on the Use of Digoxin - Mohammad Shenasa
Discussion of ISCP 2017 - Sudden Cardiac Death and Syncope - Joint Session ISCP and ESC WG of Pharmacotherapy
Loading Simple Education